The attitudes of women with BRCA1 and BRCA2 mutations toward clinical breast examinations and breast self-examinations

Journal of Women's Health

Volumn 18, Issue 7, 2009, Pages 1019-1024

  Spiegel, Tirtza N ^a   Hill, Kimberley A ^a   Warner, Ellen ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; FEMALE; GENE MUTATION; HEALTH CARE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; WOMEN'S HEALTH;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; PHYSICAL EXAMINATION;

EID: 70349224317     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1076     Document Type: Article

References (30)

1. Van Dooren S, Rijnsburger AJ, Seynaeve C, et al. Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer. Community Genet 2003;6:235-241.
2. DeVita V, Lawrence S, Rosenberg A. DeVita, Hellman, and Rosenberg's cancer: Principles & practice of oncology, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2008: vol 2.
3. Chen S, Parmigiani G. Meta-Analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
4. Hartmann LC, Schaid DJ, Woods JE. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
5. Chart PL, Franseen E. Management of women at increased risk for breast cancer: Preliminary results from a new program. Can Med Assoc J 1997;157:1235-1242.
6. Komenaka I, Russo D, Ward M, Horowitz E, Ditkoff BA, Joseph KA. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100:2079-2083.
7. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008;148:671-679.
8. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325. (Pubitemid 39223222)
9. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of woman at genetic-familial high risk for breast cancer (HIBCRIT Study): Interim results. Radiology 2007;242:698-715.
10. United States: National Comprehensive Cancer Network. Clinical practice guidelines in oncology Genetic=familial high-risk assessment: Breast and ovarian. Available at www.nccn.org=professionals=physician-gls=PDF=genetics- screening.pdf
11. Horsman D, Wilson BJ, Avard D, et al. Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. J Obstet Gynaecol Can 2007;29:45-60.
12. Eisinger F, Alby N, Bremond A, et al. Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee. Ann Oncol 1998;9:939-950. (Pubitemid 28496701)
13. Australia: National Breast and Ovarian Cancer Centre. NBOCC position statements. Early detection of breast cancer. Available at www.nbcc.org.au= media=early-detection.html
14. United Kingdom: National Institute for Health and Clinical Excellence. NICE Clinical Guideline 41. Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary, and tertiary care. Available at www.nice.org.uk=nicemedia=pdf=CG41NICE guidance.pdf
15. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-3531.
16. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992;147:1477-1488. (Pubitemid 23008477)
17. Kopans DB, Feig SA. The Canadian National Breast Screening Study: A critical review. Am J Roentgenol 1993; 161:755-760.
18. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-1256.
19. Lynch BJ, Holden JA, Buys SS, Neuhausen SL, Gaffney DK. Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 1998;29:1240-1244.
20. Tilanus-Linthorst MMA, Obdeijn IM, Hop WCJ, et al. BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials. Clin Cancer Res 2007;13:7357-7362.
21. MARIBS Study Group. Screening with magnetic resonance imaging and mammography of a U.K. population at high familial risk of breast cancer: A prospective multicentre cohort study. Lancet 2005;365:1769-1778.
22. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-8476.
23. Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437.
24. Hill KA, Warner E, Esplen MJ, Butler K, Bigenwald R. Distress and breast cancer anxiety among BRCA mutation carriers participating in MRI-based screening. Psycho-Oncology 2006;15:S267.
25. Thomas DB, Gao DL, Ray RM, et al. Self-randomized trial of breast self-examination in Shanghai: Final results. J Natl Cancer Inst 2002;94:1445-1457.
26. Semiglazov VF, Manikhas AG, Moiseenko VM, et al. Results of a prospective randomized investigation [(Russia= St.Petersburg)=WHO] to evaluate the significance of self-examination for the early detection of breast cancer. Vopr Onkol 2003;49:434-441.
27. Baxter N, with the Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001;164:1837-1846.
28. Hogg W, Lemelin J, Moroz I, Soto E, Russel G. Improving prevention in primary care: Evaluating the sustainability of outreach facilitation. Can Fam Physician 2008;54:712-720.
29. United Kingdom: National Health Services cancer screening programmes. Be breast aware. Available at cancerscreening.org.uk=breastscreen= breastaware022004.pdf
30. Warner E, Carroll J, Heisey R, et al. Educating women about breast cancer. An intervention for women with a family history of breast cancer. Can Fam Physician 2003;49: 56-63.